Application of metabolomics in the diagnosis of breast cancer: a systematic review
Journal of Cancer2020Vol. 11(9), pp. 2540–2551
Citations Over TimeTop 10% of 2020 papers
Abstract
Breast cancer (BC) remains the most frequent type of cancer in females worldwide. However, the pathogenesis of BC is still under the cloud, along with the huge challenge of early diagnosis, which is widely acknowledged as the key to a successful therapy. Metabolomics, a newborn innovative technique in recent years, has demonstrated great potential in cancer-related researches. The aim of this review is to look back on clinical and cellular metabolomic studies in the diagnosis of BC over the past decade, and provide a systematic summary of metabolic biomarkers and pathways related to BC diagnosis.
Related Papers
- → Metabolomics of Breast Cancer: A Review(2022)49 cited
- → Metabolomics of Gastric Cancer(2021)16 cited
- → A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer(2021)16 cited
- → Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients(2023)8 cited
- → Plasma metabolomic signatures of breast cancer(2023)5 cited